Abstract
Modeling studies were performed on known inhibitors of the quadruple mutant Plasmodium falciparum dihydrofolate reductase (DHFR). GOLD was used to dock 32 pyrimethamine derivatives into the active site of DHFR obtained from the x-ray crystal structure 1J3K.pdb. Several scoring functions were evaluated and the Molegro Protein-Ligand Interaction Score was determined to have one of the best correlation to experimental pK i . In conjunction with Protein-Ligand Interaction scores, predicted binding modes and key protein-ligand interactions were evaluated and analyzed in order to develop criteria for selecting compounds having a greater chance of activity versus resistant strains of Plasmodium falciparum. This methodology will be used in future studies for selection of compounds for focused screening libraries.








Similar content being viewed by others
References
National Center for Infectious Diseases, Division of Parasitic Diseases (2007) Internet references. Retrieved from http://www.cdc.gov/malaria/facts.htm 11/4/2006
Wells J (2005) Retrieved from http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2005/06/05/CMG3NCLBKA1.DTL 4/1/2007
WHO Publication (2003) Retrieved from http://www.rbm.who.int/amd2003/amr2003/pdf/ch2.pdf 4/1/2007
Hyde JE (2002) Microbes Infect 4:165
Yuthavong Y (2002) Microbes Infect 4:175
Sibley CH, Ringwald P (2006) Malar J 5:48
Ferone R (1977) Bull World Health Organ 55:291
Huennekens FM (1994) Adv Enzyme Regul 34:397
Rollo IM (1970) CRC Crit Rev Clin Lab Sci 1:565
Yuvaniyama J, Chitnumsub P, Kamchonwongpaison S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw M, Yuthavong Y (2003) Nat Struct Biol 10:357
Sirawaraporn W, Sathikul T, Sirawaraporn R, Yuthavong Y, Santi DV (1997) Proc Natl Acad Sci USA 94:1124
Kongsaeree P, Khongsuk P, Leartsakulpanich U, Chitnumsub P, Tarnchombpoo B, Walkinshaw MD, Yuthavong Y (2005) Proc Natl Acad Sci USA 102:13046
Mehlin C (2005) Comb Chem High Throughput Screen 8:5
Brady RL, Cameron A (2004) Curr Drug Targets 5:137
Delfino RT, Santos-Filho OA, Figueroa-Villar JD (2002) Biophys Chem 98:287
Kamchonwongpaison S, Quarrell R, Charoensetakul N, Ponsinet R, Vilaivan T, Vanichtanankul J, Tarnchampoo W, Sirawaraporn W, Lowe G, Yuthavong Y (2004) J Med Chem, 47:673
Parenti MD, Pacchioni S, Ferrari AM, Rastelli G (2004) J Med Chem 47:4258
Agrawal VK, Sohgaura R, Khadikar PV (2002) Bioorg Med Chem 10:2919
Mattioni BE, Jurs PC (2003) J Mol Graph Model 21:391
Gangjee A, Lee X (2005) J Med Chem 48:1448
Sutherland JJ, Weaver DF (2004) J Comput Aided Drug Des 18:309
Ganjee A, Lin X (2005) J Med Chem 48:1448
Santos-Filho OA, Hopfinger AJ (2001) J Comput Aided Mol Des 15:1
Chiu T-L, So S-S (2004) J Chem Inf Comput Sci 44:154
Hunt SY, Detering C, Varani G, Jacobus DP, Schiehser GA, Shieh H-M, Nevchas I, Terpinski J, Sibley CH (2005) Mol Biochem Parasitol 144:198
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759
Wang R, Lai L, Wang S (2002) J Comput-Aided Mol Des 16:11
Wang R, Liu L, Lai L, Tang Y (1998) J Mol Model 4:379
Warren GL et al (2006) J Med Chem 49:5912
Kitchen DB et al (2004) Nat Rev Drug Discov 3:935
Teodoro ML, Kavraki LE (2003) Curr Pharm Des 9:1635
Cavasotto CN, Abagyan RA (2004) J Mol Biol 337:209
Guex N, Peitsch MC (1997) Electrophoresis 18:2714
Molecular Operation Environment. MOE Molecular Operating Environment, Chemical Computing Group, Montreal, Quebec, Canada (2005) Retrieved from http://www.chemcomp.com 4/1/2007
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol, 267:727
Chemdraw, Cambridgesoft, Inc., Cambridge, MA (2007) Retrieved from http://www.camsoft.com 4/1/2007
Halgren TA (1996) J Comp Chem 17:490
Thomsen R, Christensen MH (2006) J Med Chem 49:3315
Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M (2005) J Mol Graph Model 23:395
Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, Fogel LJ, Freer ST (1995) Chem Biol 2:317
Gehlhaar DK, Bouzida D, Rejto PA, In: Parrill L, Rami Reddy M (eds), Rational drug design: novel methodology and practical applications, American Chemical Society, Washington, DC (1999), 292
Jain AN (1996) J Comput Aided Mol Des 10:427
Muegge I, Martin YCA (1999) J Med Chem 42:791
Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) J Comp Chem 4:187
Acknowledgements
This work is supported by the US Army Medical Research and MaterielCommand under Contract No. W81XWH-06-C-0399. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Fogel, G.B., Cheung, M., Pittman, E. et al. Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives. J Comput Aided Mol Des 22, 29–38 (2008). https://doi.org/10.1007/s10822-007-9152-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9152-9